# ATRALIN
> **NDA022070** · New Drug Application · Sponsor: DOW PHARM · Approved 2007-07-26
## Drug
- **FDA Application Number:** NDA022070
- **Application type:** New Drug Application
- **Brand name:** ATRALIN
- **Generic name:** TRETINOIN
- **Active ingredients:** TRETINOIN
- **Dosage form:** GEL
- **Route:** TOPICAL
- **Marketing status:** Prescription
- **Sponsor:** DOW PHARM
- **Manufacturer:** Obagi Cosmeceuticals LLC
- **First approval:** 2007-07-26
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022070)
---
*AI Analytics · CC0 1.0*